SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-20-017673
Filing Date
2020-07-16
Accepted
2020-07-16 16:52:39
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea124148_s3-pluristem.htm S-3 347093
2 OPEN MARKET SALE AGREEMENTSM, DATED JULY 16, 2020, BY AND BETWEEN THE COMPANY AN ea124148ex1-2_pluristem.htm EX-1.2 223008
3 COMPOSITE COPY OF THE COMPANY'S ARTICLES OF INCORPORATION AS AMENDED ON JULY 2, ea124148ex4-1_pluristem.htm EX-4.1 21726
4 COMPOSITE COPY (MARKED) OF THE COMPANY'S ARTICLES OF INCORPORATION AS AMENDED ON ea124148ex4-2_pluristem.htm EX-4.2 21976
5 OPINION OF SULLIVAN & WORCESTER LLP ea124148ex5-1_pluristem.htm EX-5.1 17683
6 CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL. ea124148ex23-1_pluristem.htm EX-23.1 3147
7 GRAPHIC img_001.jpg GRAPHIC 12583
8 GRAPHIC ex5-1_001.jpg GRAPHIC 15439
9 GRAPHIC ex5-1_002.jpg GRAPHIC 13566
10 GRAPHIC image_001.jpg GRAPHIC 21257
  Complete submission text file 0001213900-20-017673.txt   722974
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-239890 | Film No.: 201031912
SIC: 2836 Biological Products, (No Diagnostic Substances)